Drugs for Pancreatic Cancer

Table. Drugs Prescribed for Pancreatic Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Abraxane (paclitaxel protein-bound particles; albumin-bound)
Drug company
• Bristol Myers Squibb
Indication
• First-line treatment, in combination with gemcitabine, of metastatic adenocarcinoma of the pancreas
Patient support services
• BMS Oncology Co-Pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003

Drug name (generic name)
• Lynparza (olaparib) Capsules/Tablets
Drug company
• AstraZeneca
Indication
• Maintenance treatment of patients with metastatic pancreatic cancer and deleterious or suspected deleterious germline BRCA mutation, as detected by an FDA-approved test, in adults whose disease had not progressed after 16 weeks or more of platinum-based chemotherapy in the first-line setting
Patient support services
• Lynparza Co-pay Savings Program
  844-275-2360
  
  AZ&Me Prescription Savings Program
  800-292-6363

Drug name (generic name)
• Onivyde (irinotecan liposome injection)
Drug company
• Ipsen
Indication
• Metastatic pancreatic cancer, in combination with fluorouracil and leucovorin
Patient support services
• Onivyde Copay Program
  866-435-5677
  
  Ipsen Cares Patient Assistance Program
  866-435-5677

Drug name (generic name)
• Tarceva (erlotinib) Tablets
Drug company
• Genentech
Indication
• First-line treatment of patients with locally advanced, unresectable, or metastatic pancreatic cancer, in combination with Cyramza
Patient support services
• Genentech Oncology Co-pay Assistance Program
  855-692-6729
  
  Genentech Patient Foundation
  888-941-3331